Browsing Tag
David E. Lazar
2 posts
Kala Bio launches $10m registered direct financing amid balance sheet reset and dilution concerns
Find out how Kala Bio’s $10 million at-the-market stock offering under Nasdaq rules is reshaping its balance sheet, dilution risk, and survival strategy.
Kala Bio lands $6m lifeline as David E. Lazar takes control in turnaround bid
Find out how Kala Bio’s $6 million financing and leadership reset after the failed KPI-012 trial is shaping its survival strategy and investor outlook.